Mechanism of the antiretroviral effect of dsRNA.
Müller
W E
WE
Institut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Johannes Gutenberg-Universität, Mainz, Germany.
Ushijima
H
H
Schröder
H C
HC
D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism*; D000386:AIDS-Related Complex / Q000503:physiopathology; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000503:physiopathology*; D000227:Adenine Nucleotides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents; D002455:Cell Division / Q000187:drug effects; D004722:Endoribonucleases / Q000378:metabolism; D004789:Enzyme Activation; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology*; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009843:Oligoribonucleotides / Q000494:pharmacology* / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D012330:RNA, Double-Stranded / Q000502:physiology*; D059004:Topoisomerase I Inhibitors; D019892:eIF-2 Kinase
D000227:Adenine Nucleotides; D000998:Antiviral Agents; D009843:Oligoribonucleotides; D012330:RNA, Double-Stranded; D059004:Topoisomerase I Inhibitors; C023505:2',5'-oligoadenylate; D017346:Protein Serine-Threonine Kinases; D019892:eIF-2 Kinase; D015088:2',5'-Oligoadenylate Synthetase; D004722:Endoribonucleases; C031956:2-5A-dependent ribonuclease; D011070:Poly I-C